Ryo Fujiwara

Tokyo, 1358550, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 48 publications

Blood Pressure Changes After Oral 5-Aminolevulinic Acid Hydrochloride Administered 4-8 h Before TURBT: An Additional Analysis of a Phase III Study (SPP2C102).

Blood Pressure Changes After Oral 5-Aminolevulinic Acid Hydrochloride Administered 4-8 h Before TURBT: An Additional Analysis of a Phase III Study (SPP2C102).

Journal: Life (Basel, Switzerland)

Published: March 01, 2026

Predictive Factors for Gastrointestinal and Hepatic Adverse Events During 5-Aminolevulinic Acid-Guided Photodynamic Diagnosis in Bladder Cancer: Exploratory Analysis of the Phase III SPP2C102 Trial.

Predictive Factors for Gastrointestinal and Hepatic Adverse Events During 5-Aminolevulinic Acid-Guided Photodynamic Diagnosis in Bladder Cancer: Exploratory Analysis of the Phase III SPP2C102 Trial.

Journal: International journal of urology : official journal of the Japanese Urological Association

Published: September 24, 2025

Two Cases of Metastatic Castration-Resistant Prostate Cancer With Long-Term Survival Treated With Abiraterone.

Two Cases of Metastatic Castration-Resistant Prostate Cancer With Long-Term Survival Treated With Abiraterone.

Journal: Clinical case reports

Published: July 23, 2025

Prevailing challenges in personalized treatment for metastatic renal cell carcinoma: a narrative review.

Prevailing challenges in personalized treatment for metastatic renal cell carcinoma: a narrative review.

Journal: Expert review of anticancer therapy

Published: April 10, 2025

An Excellent Clinical and Radiological Response Pattern to Pembrolizumab in a Patient With Metastatic Adrenocortical Carcinoma and Lynch Syndrome.

An Excellent Clinical and Radiological Response Pattern to Pembrolizumab in a Patient With Metastatic Adrenocortical Carcinoma and Lynch Syndrome.

Journal: IJU case reports

Published: February 19, 2025

Efficacy of photodynamic diagnosis for non-muscle invasive bladder cancer: Exploratory subject-based analysis in a prospective, single-arm, multicenter phase III trial.

Efficacy of photodynamic diagnosis for non-muscle invasive bladder cancer: Exploratory subject-based analysis in a prospective, single-arm, multicenter phase III trial.

Journal: Photodiagnosis and photodynamic therapy

Published: January 14, 2025

Correction to: Effect of extending the period from oral administration of 5-aminolevulinic acid hydrochloride to photodynamic diagnosis during transurethral resection for non-muscle invasive bladder cancer on diagnostic accuracy and safety: a single-arm multicenter phase III trial.

Correction to: Effect of extending the period from oral administration of 5-aminolevulinic acid hydrochloride to photodynamic diagnosis during transurethral resection for non-muscle invasive bladder cancer on diagnostic accuracy and safety: a single-arm multicenter phase III trial.

Journal: International journal of clinical oncology

Published: November 19, 2024

Impact of IRAES on the outcomes of pembrolizumab therapy in patients with MUC: A comprehensive analysis of severity and the type and number of affected organs.

Impact of IRAES on the outcomes of pembrolizumab therapy in patients with MUC: A comprehensive analysis of severity and the type and number of affected organs.

Journal: Urologic oncology

Published: October 20, 2024

A case of seminal vesicle metastasis from bilateral seminoma.

A case of seminal vesicle metastasis from bilateral seminoma.

Journal: IJU case reports

Published: September 30, 2024

Prognostic significance of body mass index in patients with metastatic renal cell carcinoma receiving first-line therapies.

Prognostic significance of body mass index in patients with metastatic renal cell carcinoma receiving first-line therapies.

Journal: Urologic oncology

Published: August 01, 2024

Efficacy and safety of adjuvant nivolumab after radical surgery for high-risk urothelial carcinoma: a preliminary report of real-world data from a single institution.

Efficacy and safety of adjuvant nivolumab after radical surgery for high-risk urothelial carcinoma: a preliminary report of real-world data from a single institution.

Journal: International journal of clinical oncology

Published: July 20, 2024

Clinical Outcomes and Prognostic Factors in Nonmetastatic Castration-Resistant Prostate Cancer Treated with Androgen Receptor Signaling Inhibitors Therapy.

Clinical Outcomes and Prognostic Factors in Nonmetastatic Castration-Resistant Prostate Cancer Treated with Androgen Receptor Signaling Inhibitors Therapy.

Journal: Cancers

Published: June 28, 2024

Showing 1-12 of 48

Last Updated: 09/26/2026